Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)

• Mario Martínez Soldevilla,

  Roles Data curation, Investigation, Methodology

  Affiliations Aptamer Platform, Molecular Therapeutics Program, Center for Applied Medical Research, (CIMA), Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain

  ⨯
• Sandra Hervas,

  Roles Methodology, Resources

  Affiliations Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain, Program Immunology and Immunotherapy, Center for Applied Medical Research, (CIMA), University of Navarra, Pamplona, Spain

  ⨯
• Helena Villanueva,

  Roles Investigation, Methodology

  Affiliations Aptamer Platform, Molecular Therapeutics Program, Center for Applied Medical Research, (CIMA), Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain

  ⨯
• Teresa Lozano,

  Roles Data curation, Methodology

  Affiliations Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain, Program Immunology and Immunotherapy, Center for Applied Medical Research, (CIMA), University of Navarra, Pamplona, Spain

  ⨯
• Obdulia Rabal,

  Roles Resources, Software, Supervision

  Affiliation Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Pamplona, Spain

  ⨯
• Julen Oyarzabal,

  Roles Resources, Software, Supervision

  Affiliation Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Pamplona, Spain

  ⨯
• Juan José Lasarte,

  Roles Investigation, Methodology

  Affiliations Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain, Program Immunology and Immunotherapy, Center for Applied Medical Research, (CIMA), University of Navarra, Pamplona, Spain

  ⨯
• Maurizio Bendandi,

  Roles Investigation, Methodology

  Affiliations Section on Hematology/Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Wake Forest University Baptist Healthcare Center, Winston-Salem, NC, United States of America, Section of Hematology/Oncology, Department of Internal Medicine, W.G Hefner VA Medical Center, Salisbury/Charlotte, NC, United States of America

  ⨯
• Susana Inoges,

  Roles Investigation, Methodology

  Affiliations Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain

  ⨯
• Ascensión López-Díaz de Cerio,

  Roles Investigation, Methodology

  Affiliations Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain, Department of Immunology and Immunotherapy, University Clinic of Navarra, Pamplona, Spain

  ⨯
• Fernando Pastor

  Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Validation, Visualization, Writing – original draft

  * E-mail: fpasrodri@unav.es

  Affiliations Aptamer Platform, Molecular Therapeutics Program, Center for Applied Medical Research, (CIMA), Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra (IDISNA), Recinto de Complejo Hospitalario de Navarra, Pamplona, Spain

  http://orcid.org/0000-0003-0432-3133

  ⨯